Literature DB >> 16401478

GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.

Xinfu Guan1, Heidi E Karpen, John Stephens, John T Bukowski, Sanyong Niu, Guangcheng Zhang, Barbara Stoll, Milton J Finegold, Jens J Holst, Darryl Hadsell, Darry L Hadsell, Buford L Nichols, Douglas G Burrin.   

Abstract

BACKGROUND & AIMS: Glucagon-like peptide-2 (GLP-2) is a nutrient-responsive hormone that exerts diverse actions in the gastrointestinal tract, including enhancing epithelial cell survival and proliferation, mucosal blood flow, and nutrient uptake and suppressing gastric motility and secretion. These actions are mediated by the G-protein-coupled receptor, GLP-2R. Cellular localization of the GLP-2R and the nature of its signaling network in the gut, however, are poorly defined. Thus, our aim was to establish cellular localization of GLP-2R and functional connection to vascular action of GLP-2 in the gut.
METHODS: Intestinal cellular GLP-2R localization was determined with real-time, quantitative reverse-transcription polymerase chain reaction (qRT-PCR) of laser capture microdissected subtissue and fluorescence in situ hybridization and also with double and/or triple immunostaining of human and pig tissue using a validated GLP-2R polyclonal antibody. Superior mesenteric arterial blood flow and intestinal eNOS expression and phosphorylation were measured in TPN-fed pigs acutely (4 h) infused with GLP-2.
RESULTS: We show that the porcine GLP-2R mRNA was expressed in the villus epithelium and myenteric plexus. GLP-2R protein was co-localized by confocal immunohistochemistry with serotonin in enteroendocrine cells and also with endothelial nitric oxide synthase (eNOS)-expressing and vasoactive intestinal polypeptide-positive enteric neurons. In neonatal pigs, GLP-2 infusion dose-dependently stimulated intestinal blood flow and coordinately upregulated the expression of intestinal eNOS mRNA, protein, and phosphorylation (eNOS-Ser1117).
CONCLUSIONS: We conclude that the GLP-2-induced stimulation of blood flow is mediated by vasoactive neurotransmitters that are colocalized with GLP-2R in 2 functionally distinct cell types within the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16401478     DOI: 10.1053/j.gastro.2005.11.005

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  76 in total

1.  Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.

Authors:  Bharati Kochar; Millie D Long; Edward Shelton; Lorraine Young; Francis A Farraye; Vijay Yajnik; Hans Herfarth
Journal:  J Clin Gastroenterol       Date:  2017-07       Impact factor: 3.062

2.  Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse.

Authors:  Bernardo Yusta; Dianne Matthews; Jacqueline A Koehler; Gemma Pujadas; Kiran Deep Kaur; Daniel J Drucker
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

3.  Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.

Authors:  Bernardo Yusta; Dianne Holland; James A Waschek; Daniel J Drucker
Journal:  Endocrinology       Date:  2012-04-24       Impact factor: 4.736

4.  Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.

Authors:  Andreas Vegge; Thomas Thymann; Pernille Lund; Barbara Stoll; Stine B Bering; Bolette Hartmann; Jacob Jelsing; Niels Qvist; Douglas G Burrin; Palle B Jeppesen; Jens J Holst; Per T Sangild
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-06-13       Impact factor: 4.052

Review 5.  Cholecystectomy and risk of metabolic syndrome.

Authors:  Agostino Di Ciaula; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Eur J Intern Med       Date:  2018-04-26       Impact factor: 4.487

6.  Quantitative perfusion assessment of intestinal anastomoses in pigs treated with glucagon-like peptide 2.

Authors:  Nikolaj Nerup; Linea Landgrebe Ring; Rune Broni Strandby; Charlotte Egeland; Morten Bo Søndergaard Svendsen; Jane Preuss Hasselby; Gro Linno Willemoe; Bolette Hartmann; Lars Bo Svendsen; Michael Patrick Achiam
Journal:  Langenbecks Arch Surg       Date:  2018-10-18       Impact factor: 3.445

7.  Ret heterozygous mice have enhanced intestinal adaptation after massive small bowel resection.

Authors:  Meredith C Hitch; Jennifer A Leinicke; Derek Wakeman; Jun Guo; Chris R Erwin; Kathryn J Rowland; Ellen C Merrick; Robert O Heuckeroth; Brad W Warner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

8.  Glucagon-like peptide-2 (GLP-2) increases net amino acid utilization by the portal-drained viscera of ruminating calves.

Authors:  C C Taylor-Edwards; D G Burrin; N B Kristensen; J J Holst; K R McLeod; D L Harmon
Journal:  Animal       Date:  2012-05-09       Impact factor: 3.240

9.  Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.

Authors:  Jacqueline A Koehler; Will Harper; Maja Barnard; Bernardo Yusta; Daniel J Drucker
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 10.  The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.

Authors:  Xinfu Guan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-02       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.